Pyxis Oncology, Inc. (PYXS) Gross margin 2024–2025
Pyxis Oncology, Inc. (PYXS) gross margin by fiscal year — reported gross profit divided by reported revenue.
82.8%FY2025 · since FY2024: 97.1% → 82.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 82.8% | -14.3 pp |
| FY2024 | 97.1% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More PYXS financial trends
PYXS RevenuePYXS Net incomePYXS Net marginPYXS Gross profitPYXS Operating incomePYXS Operating marginPYXS Operating cash flowPYXS Free cash flowPYXS Capital expendituresPYXS Return on equityPYXS Stock buybacksPYXS Dividends paidPYXS Total assetsPYXS Total liabilitiesPYXS Shareholders’ equityPYXS overview →